
David Woodhouse, Ph.D.
Chief Executive Officer
NGM
Dr. Woodhouse became Chief Executive Officer and a member of NGM’s board of directors in September 2018. He previously served as NGM’s Chief Financial Officer, joining the company in March 2015. From 2002 to 2015, he was an investment banker at Goldman Sachs & Co. LLC, most recently as a Managing Director in the healthcare investment banking group and co-head of biotechnology investment banking. Earlier in his career, Dr. Woodhouse worked at Dynavax Technologies and also as a research assistant at Amgen, Inc. Dr. Woodhouse received a B.A. in pharmacology from the University of California, Santa Barbara, an M.B.A. from the Tuck School of Business at Dartmouth and a Ph.D. in molecular pharmacology from Stanford University School of Medicine.

Erin Henry, Ph.D.
Head of Ophthalmology
Specialties: Ophthalmology, Neuroscience • 10+ years of pharmaceutical experience in Medical Affairs, Product Development, and Marketing • Deep therapeutic area expertise in age-related macular degeneration and retinal vascular disease • Well established Ophthalmology/Retina healthcare provider network • Product launch planning and execution experience • Global company-sponsored trial (Phase Ia-IV) and investigator initiated trial (IST/IIS) experience • Strong basic research background in biochemistry and neuroscience

Mark Solloway, Ph.D.
Principal Scientist, Biology
Dr. Solloway is a research biologist with over 15 years of biotechnology industry experience in target discovery, validation, and therapeutic drug development. He joined NGM Bio in 2015 and is responsible for NGM’s Ocular Biology Research efforts. Dr. Solloway is also leading a focused effort to develop and evaluate novel therapeutics in Oncology at NGM. Prior to NGM, Dr. Solloway spent 10 years at Genentech in which his primary focus was on the development and utilization of mouse models for the study of metabolic disease. Dr. Solloway received a Bachelor of Science in Biochemistry and Cell Biology from University of California, San Diego and a Ph.D. in Genetics from Harvard University.

Charles C. Wykoff, M.D., Ph.D.
Director of Research
Retina Consultants Houston and the Greater Houston Retina Research Foundation
Charles C. Wykoff, MD, PhD is Director of Research at Retina Consultants of Texas; Chairman of Research, Retina Consultants of America; and Deputy Chair of Ophthalmology for the Blanton Eye Institute, Houston Methodist Hospital. He received his baccalaureate from MIT, PhD from Oxford, MD from Harvard, completed clinical training at Bascom Palmer Eye Institute, and is an active medical and surgical retina specialist. He is passionate about translational research, clinical trial design, accelerating drug-development programs and has published over 200 peer-reviewed manuscripts. He serves on multiple scientific and medical advisory boards, safety monitoring committees, and global steering committees for endeavors spanning the innovative process from early to late-stage developments. He is President of the Vit-Buckle Society (2021-2023), serves on the ASRS Board of Directors, is a founding member of the Ophthalmology Retina Editorial Board, and is the Chief Medical Editor for Retina Specialist. He has been awarded multiple Achievement, Honor and Senior Honor Awards including the ASRS Young Investigator and the AAO Secretariat Awards. His guiding philosophy is to build and strengthen innovative, ethical teams focused on developing new approaches to improving outcomes for blinding diseases.

Siobhan Nolan Mangini
Chief Financial Officer
NGM
Prior to joining NGM, Ms. Nolan Mangini served as President and Chief Financial Officer (CFO) of Castlight Health, a publicly traded San Francisco-based healthcare technology company. She joined Castlight in 2012 and assumed roles of increasing responsibility, ultimately being appointed CFO in 2016 followed by her additional appointment as President in 2019. At Castlight, Ms. Nolan Mangini was responsible for a wide range of functions including strategic and corporate planning, finance, investor relations, people, legal, real estate, customer support and business operations. Prior to joining Castlight, Ms. Nolan Mangini worked as a management consultant at Bain & Company, specializing in the health care and private equity practices. She began her career at the Henry J. Kaiser Family Foundation as a financial associate responsible for managing the allocation of the foundation’s endowment. Ms. Nolan Mangini currently serves on the Board of Directors of Artemis Health. Ms. Nolan Mangini has a Master of Business Administration from the Graduate School of Business at Stanford University, a Master of Public Administration from the Kennedy School of Government at Harvard University and a Bachelor of Science in Economics from the Wharton School at the University of Pennsylvania.